Company / Inventory per Share
ADMA Biologics, Inc. Inventory per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory per Share
$0.87
FY2025
5-year range
$0.75 / $1.19
FY2021-FY2025
Trend
+15.9%
vs FY2024
Sector context
#40 of 105
Health Care
What the data says
At $0.87, ADMA Biologics, Inc.'s inventory per share ranks #40 of 105 in the Health Care sector. Inventory per Share returned to growth in FY2025 after 4 years of decline, reaching $0.87.
Based on SEC 10-K filings.
0.87 in FY2025 with a 5-year CAGR of -8.7%.
Improved from $0.78 to $0.87 over the past 2 years.
Health Care sector context is included.
Inventory per Share over time
Growth rates
- 3-Year CAGR
- +1.5%
- 5-Year CAGR
- -8.7%
- 10-Year CAGR
- -
Sector benchmark
#40 of 105 in Health CareTop 38% of 105This company $0.87 Sector average $30.82
▼
-97.2% below sector average
Key checks
Key Insights
- In FY2025, inventory per share increased 15.9% year-over-year.
- Ranks #40 out of 105 companies in the Health Care sector.
- Peak inventory per share was recorded in FY2020.
- Lowest inventory per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 3.37 (safe zone, above 2.9 threshold)
- Strong profit margin: 46.4%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Inventory per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.87 | +15.9% |
| FY2024 | $0.75 | -3.4% |
| FY2023 | $0.78 | -6.5% |
| FY2022 | $0.83 | -29.9% |
| FY2021 | $1.19 | -13.5% |
| FY2020 | $1.37 | +20.1% |
| FY2019 | $1.14 | +125.8% |
| FY2018 | $0.51 | -48.3% |
| FY2017 | $0.98 | +109.1% |
| FY2016 | $0.47 | +26.4% |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026